NCT05209295
A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies basic_science 1 recruiting NCT05916560
A Study of LY3437943 in Participants With Impaired and Normal Liver Function basic_science 1 recruiting NCT06575959
A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030) No drug interventions treatment 1 recruiting NCT06390410
A Pharmacokinetic Study of Simufilam in Subjects with Impaired Hepatic Function basic_science 1 recruiting NCT06620731
Clinical Trial of FCN-437c Capsule in Patients With Hepatic Insufficiency No drug interventions other 1 completed NCT02090621
Extracorporeal Photopheresis After Liver Transplant No drug interventions treatment 2 completed NCT03341884
A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants treatment 1 completed NCT04226833
A Study to Investigate the Effect of Impaired Hepatic Function on the Pharmacokinetics of Entrectinib in Volunteers With Different Levels of Hepatic Function treatment 1 completed NCT03842761
A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems No drug interventions treatment 1 completed NCT01512693
Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070) treatment 1 completed NCT01186588
A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function Not Available 1 completed NCT01836185
A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment basic_science 1 completed NCT01019070
Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032 Not Available 1 completed NCT00969813
A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function Not Available 1 completed NCT01111318
Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function treatment 1 completed NCT00692341
Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics treatment 1 completed NCT02753517
Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies No drug interventions screening Not Available unknown_status NCT00948558
Citrate Pharmacokinetics and Regional Citrate Anticoagulation in CRRT No drug interventions Not Available Not Available unknown_status NCT01043926
Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017) treatment 1 completed NCT01860326
Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects Not Available 1 completed NCT02191865
Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers treatment 1 completed NCT02265627
Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers treatment 1 completed NCT00968591
Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency other 1 completed NCT02184091
Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine treatment 1 completed NCT05440344
A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function basic_science 1 completed NCT03306667
Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency) basic_science 1 completed NCT04993404
Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function treatment 1 completed NCT05093972
Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014) treatment 1 not_yet_recruiting NCT00509210
Study of Telaprevir in Subjects With Hepatic Impairment basic_science 1 completed NCT02387814
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment basic_science 1 completed NCT01261923
Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease Not Available 1 / 2 completed NCT00805090
Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects Not Available 1 completed NCT00645021
Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug treatment 1 completed NCT02800421
Prognostic Impact of Organ Damage in STEMI Patients No drug interventions Not Available Not Available completed NCT00416702
Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function treatment 1 completed NCT02457702
Mitochondrial Function in Patients With Severe Liver Disease No drug interventions basic_science Not Available terminated NCT01043887
Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046) treatment 1 completed NCT00314054
Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults treatment 1 completed NCT00859053
Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment Not Available 1 completed NCT01273493
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction treatment 1 completed NCT02170571
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function treatment 1 completed NCT01870388
A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease basic_science 1 completed NCT04170309
Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases Not Available Not Available completed NCT02894385
Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201) other 1 completed NCT00929032
Liver Transplantation and Reticuloendothelial Clearance Capacity No drug interventions Not Available Not Available completed NCT05882032
A Study of LY3502970 in Participants With Impaired and Normal Liver Function basic_science 1 recruiting NCT02249442
Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency treatment 1 completed NCT03940742
A Study of Tirzepatide in Participants With Impaired Liver Function basic_science 1 completed NCT01751399
A Single Dose Study of LY2605541 in Participants With Liver Impairment treatment 1 completed NCT01797536
The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009) treatment 1 completed NCT04147936
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency No drug interventions basic_science Not Available completed NCT01475136
A Study of LY2140023 in Hepatically-Impaired Participants basic_science 1 completed NCT04867941
A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196 treatment 1 completed NCT02161224
A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function basic_science 1 completed NCT06176716
Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride No drug interventions other 1 recruiting NCT00781430
Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease Not Available 1 completed NCT00144248
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions treatment 4 completed NCT03968848
Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite treatment 1 completed NCT01891526
Single Dose of 9-cis-retinoic Acid in Hepatic Patients Not Available Not Available completed NCT03295266
Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006) No drug interventions treatment 1 terminated NCT02183376
Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects treatment 1 completed NCT00931060
Effects of Branched-Chain Amino Acids on Muscle Ammonia Metabolism in Patients With Cirrhosis and Healthy Subjects No drug interventions Not Available Not Available completed NCT06190691
Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants basic_science 1 completed NCT00623662
Preoperative Glucose Infusion: a Novel Strategy to Improve Liver Function After Liver Resection No drug interventions prevention Not Available unknown_status NCT05661344
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems treatment 1 completed NCT04097704
Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort No drug interventions Not Available Not Available completed NCT05731895
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems treatment 1 completed NCT02259855
Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment treatment 1 completed NCT02813538
Major Liver Resection: Early Clotting Disorders and Functional Impairment. Not Available Not Available completed